DK3593788T3 - Oftalmiske sammensætninger indeholdende et nitrogenoxid-frigørende prostamid - Google Patents

Oftalmiske sammensætninger indeholdende et nitrogenoxid-frigørende prostamid Download PDF

Info

Publication number
DK3593788T3
DK3593788T3 DK19185400.9T DK19185400T DK3593788T3 DK 3593788 T3 DK3593788 T3 DK 3593788T3 DK 19185400 T DK19185400 T DK 19185400T DK 3593788 T3 DK3593788 T3 DK 3593788T3
Authority
DK
Denmark
Prior art keywords
prostamide
releasing
compositions containing
nitric oxide
ophthalmic compositions
Prior art date
Application number
DK19185400.9T
Other languages
English (en)
Inventor
Frédéric Pilotaz
Alan L Weiner
Marina Do
Julien Saldo
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of DK3593788T3 publication Critical patent/DK3593788T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK19185400.9T 2018-07-12 2019-07-10 Oftalmiske sammensætninger indeholdende et nitrogenoxid-frigørende prostamid DK3593788T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18290082 2018-07-12

Publications (1)

Publication Number Publication Date
DK3593788T3 true DK3593788T3 (da) 2021-01-11

Family

ID=63012964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19185400.9T DK3593788T3 (da) 2018-07-12 2019-07-10 Oftalmiske sammensætninger indeholdende et nitrogenoxid-frigørende prostamid

Country Status (28)

Country Link
US (5) US10688073B2 (da)
EP (2) EP3593788B1 (da)
JP (4) JP6672512B2 (da)
KR (1) KR102861273B1 (da)
CN (2) CN110237031B (da)
AR (1) AR115734A1 (da)
AU (2) AU2019300203B2 (da)
BR (1) BR112021000240A2 (da)
CA (1) CA3105989A1 (da)
CY (1) CY1123706T1 (da)
DK (1) DK3593788T3 (da)
ES (2) ES2847853T3 (da)
HR (2) HRP20251098T1 (da)
HU (2) HUE052747T2 (da)
LT (1) LT3593788T (da)
MA (2) MA52258B1 (da)
MD (2) MD3718535T2 (da)
MX (2) MX2021000411A (da)
MY (1) MY205816A (da)
PH (1) PH12020552112A1 (da)
PL (2) PL3593788T3 (da)
PT (1) PT3593788T (da)
RS (2) RS67054B1 (da)
SG (1) SG11202100064WA (da)
SI (1) SI3593788T1 (da)
SM (2) SMT202100034T1 (da)
TW (1) TWI839364B (da)
WO (1) WO2020011845A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SMT202100034T1 (it) 2018-07-12 2021-03-15 Nicox Sa Composizioni oftalmiche contenenti una prostamide che rilascia ossido nitrico
JP2024533601A (ja) * 2021-09-20 2024-09-12 ニコックス エス．エー． 神経保護剤としての一酸化窒素放出プロスタミド
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
US20260053768A1 (en) * 2024-05-07 2026-02-26 Maher Hadaya Sustained Nitric Oxide Releasing Drug Delivery Systems

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
EA201070483A1 (ru) * 2007-10-16 2010-10-29 Сан Фарма Адвансед Ресьёрч Компани Лимитед Новые офтальмологические композиции
AR076731A1 (es) 2008-05-09 2011-07-06 Pfizer Prostamidas donadoras de oxido nitrico, uso de los mismos y composiciones farmaceuticas
BRPI0918253A2 (pt) 2008-09-12 2015-12-15 Critical Pharmaceuticals Ltd aperfeicoamento na absorcao de agentes terapeuticos atraves das membranas mucosas ou da pele
EP2566453A4 (en) * 2010-05-07 2014-05-07 Sun Pharma Advanced Res Co Ltd NOVEL OPHTHALMIC COMPOSITIONS
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
CN103764120A (zh) * 2011-06-29 2014-04-30 阿勒根公司 聚乙二醇15羟基硬脂酸酯制剂
EP2739264A1 (en) 2011-08-02 2014-06-11 Cipla Limited Pharmaceutical composition comprising ebastine and fluticasone
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
CN105380901B (zh) * 2015-11-18 2018-07-17 侯宇华 一种他氟前列素滴眼剂及其制备方法
SMT202100034T1 (it) * 2018-07-12 2021-03-15 Nicox Sa Composizioni oftalmiche contenenti una prostamide che rilascia ossido nitrico

Also Published As

Publication number Publication date
MY205816A (en) 2024-11-14
BR112021000240A2 (pt) 2021-04-06
SG11202100064WA (en) 2021-02-25
SMT202500425T1 (it) 2026-01-12
HRP20210138T1 (hr) 2021-03-19
MD3593788T2 (ro) 2021-03-31
MA48919B1 (fr) 2021-02-26
US20200206176A1 (en) 2020-07-02
US12186295B2 (en) 2025-01-07
ES3036636T3 (en) 2025-09-23
JP2022116147A (ja) 2022-08-09
MA48919A (fr) 2020-01-15
CN111249228A (zh) 2020-06-09
AU2025203019A1 (en) 2025-05-15
KR20210032435A (ko) 2021-03-24
EP3593788A1 (en) 2020-01-15
RS67054B1 (sr) 2025-08-29
SMT202100034T1 (it) 2021-03-15
CY1123706T1 (el) 2022-05-27
ES2847853T3 (es) 2021-08-04
KR102861273B1 (ko) 2025-09-17
WO2020011845A1 (en) 2020-01-16
JP2020011955A (ja) 2020-01-23
US12178793B2 (en) 2024-12-31
AU2019300203A1 (en) 2021-03-04
TWI839364B (zh) 2024-04-21
AU2019300203B2 (en) 2025-01-30
US10688073B2 (en) 2020-06-23
JP7080268B2 (ja) 2022-06-03
JP7397910B2 (ja) 2023-12-13
MD3718535T2 (ro) 2025-08-31
MA52258B1 (fr) 2025-07-31
LT3593788T (lt) 2021-04-12
CA3105989A1 (en) 2020-01-16
US20200016108A1 (en) 2020-01-16
CN110237031B (zh) 2022-02-11
JP2020105201A (ja) 2020-07-09
US20210220316A1 (en) 2021-07-22
MX2021000411A (es) 2021-03-25
MX2023007091A (es) 2023-06-27
AR115734A1 (es) 2021-02-17
JP6672512B2 (ja) 2020-03-25
US20250073196A1 (en) 2025-03-06
US20210128458A1 (en) 2021-05-06
SI3593788T1 (sl) 2021-03-31
PH12020552112A1 (en) 2021-05-31
HUE052747T2 (hu) 2021-05-28
MA52258A (fr) 2021-02-17
PL3718535T3 (pl) 2025-10-13
EP3718535B1 (en) 2025-06-18
EP3718535A1 (en) 2020-10-07
TW202019401A (zh) 2020-06-01
PT3593788T (pt) 2021-01-21
CN111249228B (zh) 2022-05-03
HRP20251098T1 (hr) 2025-11-07
RS61348B1 (sr) 2021-02-26
HUE072927T2 (hu) 2025-12-28
JP2024023498A (ja) 2024-02-21
EP3718535C0 (en) 2025-06-18
US11020368B2 (en) 2021-06-01
CN110237031A (zh) 2019-09-17
EP3593788B1 (en) 2020-10-28
PL3593788T3 (pl) 2021-05-31

Similar Documents

Publication Publication Date Title
EP4064259A4 (en) DISPLAY DEVICE
DK3890488T3 (da) Herbicide sammensætninger
EP3731061B1 (en) DISPLAY DEVICE
EP3761960C0 (en) OPHTHALMIC FORMULATION
EP3971658C0 (en) WEARABLE DEVICE
EP3960117C0 (en) ELASTIC ORTHODONTIC APPLIANCES
DK3685673T3 (da) Vegansk chokolade
EP4064261B1 (en) DISPLAY DEVICE
DE112020001082A5 (de) Löschvorrichtung
EP3857601A4 (en) Display apparatus
EP3836222B1 (en) DISPLAY DEVICE
EP3764154C0 (en) DISPLAY DEVICE
DK3993626T3 (da) Herbicide sammensætninger
EP3709356B1 (en) DISPLAY DEVICE
IL283673A (en) Deuterated analogs of acetyl-leucine
EP3890487C0 (en) HERBICIDAL COMPOSITIONS
EP4086882A4 (en) Display device
UA42368S (uk) Дисплейний пристрій
EP4035739A4 (en) HYDROGEL
EP3861039C0 (fr) Compositions d'hydrogels
EP4026512C0 (en) NEW GUTTA-PERCHA CUTTING DEVICE POINT
EP3718535C0 (en) Ophthalmic compositions containing a nitric oxide releasing prostamide
IL291356A (en) Agrochemical formulation containing a sulfopolymer
EP4039248C0 (en) Ophthalmic composition
EP4053827A4 (en) Display device